Search for: "ASTRAZENECA UK LIMITED"
Results 21 - 40
of 73
Sort by Relevance
|
Sort by Date
29 Jun 2018, 2:35 pm
ASTRAZENECA – SUPREME COURT Eelco Bergsma reports in the "EPLAW" Blog on this case which dealt with whether the description of the patent provided for a limiting definition of the claim.DesignsMoving on to some design news, the blog Marques reported that the Hague System expands to UK. [read post]
2 Jul 2017, 12:52 am
AstraZeneca brought an action for patent infringement against Apotex. [read post]
1 Jul 2017, 9:39 am
AstraZeneca brought an action for patent infringement against Apotex. [read post]
3 Apr 2017, 10:55 pm
(T-321/05 AstraZeneca v Commission [2010] ECR II-2805). [read post]
25 Jan 2017, 10:48 pm
Andrew considered that the days of proffering a raft of last minute amendments are over both in the UK and at the EPO. [read post]
7 Nov 2016, 1:34 pm
The recent decision by the UK High Court regarding Brexit may well be cited in Canada with respect to limits on the royal prerogative and other issues.Many experts do not believe that Eli Lilly should or will win the NAFTA challenge on the merits. [read post]
30 Jul 2015, 4:46 am
– Three (19%) impose geographic restrictions on which employees are included in the comparator group (e.g., limiting to strictly U.S. or UK employees). [read post]
8 Jun 2015, 4:20 am
This question, posed in relation to the law of the Bahamas, was answered by the Privy Council in Gold Rock Limited v Nylund Hylton [2015] UKPC 17, about which guest blogger Kevin Winters tells all.Copyright cases for the CJEU: have your sayTwo more references, respectively from Germany and the Netherlands, are heading the CJEU’s desks. [read post]
22 May 2015, 10:38 am
See Sales J's original judgment here (or the summary on PatLit here).BackgroundIn 2009, AstraZeneca was granted European Patent number EP (UK) 1 020 461 (the 'Patent'). [read post]
14 May 2015, 4:00 am
In limited circumstances, it remains a legitimate validity challenge. [read post]
8 Sep 2014, 4:55 am
.* The skilled person - more knowledgeable than ever beforeDavid covers the exciting pharma-patent ruling in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) by Mr Justice Sales in the Patents Court for England and Wales, which focuses on the concept of Common General Knowledge (CGK). [read post]
4 Sep 2014, 1:00 am
So changing the CGK analysis inevitably changes the test for inventive step.All of this helps explain why the IPKat is so exercised by yesterday’s decision in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat), decided by Mr Justice Sales in the Patents Court. [read post]
27 Jul 2014, 5:07 pm
On 22 July 2014, HHJ Moloney QC heard an application in the harassment case of AstraZeneca UK Ltd & anr v Mathai & ors. [read post]
14 May 2014, 6:54 pm
The UK decision in Ranbaxy v AstraZeneca [2011]EWHC 1831 [on which see Katpost here] throws a little more light on this issue. [read post]
29 Nov 2012, 5:21 am
AstraZeneca UK Limited v. [read post]
20 Apr 2012, 12:06 am
The report on how homelessness and health are intertwined was presented to government, Minister of State for Care services Paul Burstow who said; "I very much welcome the research carried out by Depaul UK and AstraZeneca on the health of the young homeless population". [read post]
27 Mar 2012, 8:51 am
In AstraZeneca UK Limited, et al. v. [read post]
23 Feb 2012, 8:46 pm
In this particular case, AstraZeneca Pharmaceutical LP and AstraZeneca UK Limited (together, "Astra") had filed suit against Intellipharmaceutics Corp. [read post]
13 Feb 2012, 12:54 pm
The Court agreed with defendant Watson Laboratories that "the specification provide[d] an express definition that limit[ed] the term ... to an alkali metal ion, alkaline earth metal ion, or ammonium ion" AstraZeneca UK Ltd. v. [read post]
3 Aug 2011, 3:31 am
422/10 Georgetown University v Comptroller-General of Patents, Designs and Trade Marks (The SPC Blog) France: Limitation of the French designation of a European patent: before which office? [read post]
